Increased risk of vulvovaginal candidiasis in diabetic patients under treatment with SGLT2 inhibitors.

Increased risk of vulvovaginal candidiasis in diabetic patients under treatment with SGLT2 inhibitors.

Med Clin (Barc). 2020 Aug 17;:

Authors: Nieto-Benito LM, Barchino-Ortiz L

PMID: 32819773 [PubMed - as supplied by publisher]